Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the ...

The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...

Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...

A $10 billion settlement to end litigation over Johnson & Johnson's baby powder, which was recalled after it was alleged to ...

The FDA today issued a notice informing customers of updated instructions for the Johnson & Johnson Abiomed Impella RP heart ...

Medtech giants are doubling down on robotic surgery systems as hospitals see fewer complications and shorter stays.

The Class I recall warned that the tip of guidewires or other medical devices may come into contact with the Impella pump during insertion, adjustment or removal. This interaction could result in ...

Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.

(RTTNews) - Johnson & Johnson (JNJ ... to placebo across all clinical and endoscopic measures consistent with the FDA-approved intravenous induction regimen in this population.

CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...

A class action filed today says Kiwis have been deceived for about two decades through the use of phenylephrine in cold and ...